We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Authors
van Breeschoten, Jesper; Wouters, Michel W. J. M.; Hilarius, Doranne L.; Haanen, John B.; Blank, Christian U.; Aarts, Maureen J. B.; van den Berkmortel, Franchette W. P. J.; de Groot, Jan-Willem B.; Hospers, Geke A. P.; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Roos S.; Suijkerbuijk, Karijn P. M.; Blokx, Willeke A. M.; Tije, Bert-Jan J. ten; Veldt, Astrid A. M. van der; Vreugdenhil, Art; Boers-Sonderen, Marye J.; van den Eertwegh, Alfonsus J. M.
- Publication
British Journal of Cancer, 2022, Vol 126, Issue 9, p1362
- ISSN
0007-0920
- Publication type
corrected article
- DOI
10.1038/s41416-022-01772-z